Wall Street Zen upgraded shares of Perrigo (NYSE:PRGO – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday,Wall Street Zen reports.
Separately, Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Perrigo currently has a consensus rating of “Hold” and a consensus price target of $19.33.
View Our Latest Stock Report on Perrigo
Perrigo Trading Up 4.1%
Perrigo (NYSE:PRGO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the business earned ($0.06) earnings per share. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Analysts anticipate that Perrigo will post 2.18 earnings per share for the current year.
Perrigo Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 8.2%. The ex-dividend date was Friday, August 28th. Perrigo’s dividend payout ratio (DPR) is -9.27%.
Institutional Trading of Perrigo
A number of institutional investors and hedge funds have recently bought and sold shares of PRGO. Bank of America Corp DE lifted its holdings in shares of Perrigo by 25.5% during the 1st quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock valued at $16,847,000 after acquiring an additional 318,248 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its holdings in Perrigo by 28.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock valued at $64,848,000 after purchasing an additional 1,029,770 shares in the last quarter. Gamco Investors INC. ET AL raised its position in Perrigo by 29.7% in the first quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock valued at $15,013,000 after purchasing an additional 320,081 shares during the period. Diamond Hill Capital Management LLC Investment Advisor acquired a new position in shares of Perrigo during the second quarter worth about $4,066,000. Finally, Empowered Funds LLC boosted its position in shares of Perrigo by 41.6% in the first quarter. Empowered Funds LLC now owns 511,872 shares of the company’s stock worth $5,498,000 after buying an additional 150,438 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women’s health.
The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.
Further Reading
- Five stocks we like better than Perrigo
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
